Hepatitis B core‐related antigen levels predict recurrence‐free survival in patients with HBV‐associated early‐stage hepatocellular carcinoma: results from a Dutch long‐term follow‐up study

Prognosis of hepatitis B (HBV)‐associated hepatocellular carcinoma (HCC) is poor due to high rates of HCC recurrence and progression of underlying liver disease. We studied whether serum hepatitis B core‐related antigen (HBcrAg) levels could predict HCC recurrence and outcome in HBV associated. High...

Descripción completa

Detalles Bibliográficos
Autores principales: Beudeker, Boris J. B., Groothuismink, Zwier M. A., de Man, Robert A., Witjes, Caroline D. M., van der Eijk, Annemiek A., Boonstra, Andre, Sonneveld, Milan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756674/
https://www.ncbi.nlm.nih.gov/pubmed/32869922
http://dx.doi.org/10.1111/jvh.13394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756674/
https://www.ncbi.nlm.nih.gov/pubmed/32869922
http://dx.doi.org/10.1111/jvh.13394

Ejemplares similares